Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Slashing General Motors Company (GM) Proves Unwise as Kyle Bass’ Stock Picks Did Terribly in Q1, Tanking by 18.9%

Page 1 of 2

Kyle BassHeyman Advisors had a very poor quarter that was characterized by its selloff of General Motors Company (NYSE:GM), a company in which Bass had previously declared bullish sentiment towards. Bass’ five reported long positions in companies with market-caps of at least $1 billion lost 18.9% during the first quarter according to our metric of weighted average returns based on the equity portfolio of the fund at the start of quarter in question. That performance landed Bass the dubious distinction of being the worst performing fund in our database of nearly 700 actively reporting funds during the first quarter, and also dropped his one-year returns to -37.3%. Note however that Bass’ actual returns may be slightly or even significantly different, as his equity positions may only be a small part of his overall portfolio.

Kyle Bass

General Motors Company (NYSE:GM) was one of those five positions, though it was slashed dramatically during the fourth quarter, by 98% to just under 126,000 shares valued at $4.40 million as Bass seemingly gave up on the auto maker. That came as a surprise given that Bass had opened his large position in GM just over one year ago, during the fourth quarter of 2013 and declared shortly afterwards that the stock was undervalued and could hit $50 over the next 12 to 18 months. Fast forward to the fourth quarter of 2014 and Bass ended up selling off most of his position at a loss from what he purchased it for one year prior. The selloff had to sting even more after shares of General Motors Company (NYSE:GM) appreciated by more than 10% during the first two months of 2015, eventually finishing the first quarter of the year up by 8.29%. While hanging onto his GM shares would not have saved Bass from a poor quarter, it may have been enough to spare him from being the worst performing fund in our database.

So where did it all go wrong for Bass? It begins with his top position in Nationstar Mortgage Holdings Inc (NYSE:NSM). His 3.39 million shares of Nationstar Mortgage Holdings Inc (NYSE:NSM),valued at $95.53 million were a decrease of 19% from the previous quarter, but that was little consolation as the company’s shares dipped by over 12% during the quarter. Nationstar Mortgage Holdings Inc (NYSE:NSM) shares were actually up by over 10% in late March until it announced a public offering of an additional 17.5 million shares and entered into agreements with Ocwen Financial Corp (NYSE:OCN) to purchase $60 billion of mortgage servicing rights. Shares tanked over 20% in the following week. That was also bad news for Michael Novogratz of Fortress Investment Group, who had the second greatest exposure to the stock after Bass.

Speaking of Ocwen Financial Corp (NYSE:OCN), it was an even bigger loser during the quarter and Bass also had a large position in it, his third largest, consisting of 3.26 million shares valued at $49.28 million. Ocwen Financial Corp (NYSE:OCN) crumbled by more than 45% during the quarter, not on the aforementioned deal, but over concerns that the company could be suspended from doing business in California as it faces the wrath of regulators there for not providing them with information that proves the mortgage services of the company were complying with state laws. Other investors believe the stock is a great buy now however, one that will make up all of its lost ground once the regulatory fervor subsides. Bass also has the largest exposure to Ocwen, followed by Noah Levy and Eugene Dozortsev’s Newtyn Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!